L-Glutamic acid
Based on 15 publication(s) in Google Scholar
L-Glutamic acid is an excitatory amino acid neurotransmitter that acts as an agonist for all subtypes of glutamate receptors (metabolic rhodophylline, NMDA, and AMPA). L-Glutamic acid has an agonist effect on the release of DA from dopaminergic nerve endings. L-Glutamic acid can be used in the study of neurological diseases. L-Glutamic acid acts at ionotropic and metabotropic glutamate receptors.
For research use only. We do not sell to patients.
- Purity: 99.96%
- CAS No.: 56-86-0
- Formula: C5H9NO4
- Molecular Weight:147.13
-
Storage:
Store at room temperature 3 years.
In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) L-Glutamic acid
More- Nature. 2025 Jul;643(8070):192-200. [Abstract]
- Adv Sci (Weinh). 2025 Oct 5:e11194. [Abstract]
- Adv Sci (Weinh). 2024 Dec 16:e2411479. [Abstract]
- Redox Biol. 2024 May:71:103112. [Abstract]
- J Transl Med. 2024 Feb 18;22(1):178. [Abstract]
- Cancer Immunol Immunother. 2025 Jun 7;74(8):240. [Abstract]
- Int Immunopharmacol. 2025 Dec 21:170:116080. [Abstract]
- Neuropharmacology. 2025 Jun 15:271:110405. [Abstract]
- J Inflamm Res. 2025 Jan 27:18:1235-1254. [Abstract]
- Neurochem Int. 2023 Oct:169:105587. [Abstract]
- Fitoterapia. 2026 Apr:190:107182. [Abstract]
- Amino Acids. 2024 Sep 18;56(1):56. [Abstract]
- bioRxiv. 2026 Jan 26.
- Res Sq. 2024 Jun 03.
- Res Sq. 2024 May 20.
-
Bio/Physico-chemical Assay
-
Flow Cytometry
-
Cell Proliferation/Viability Assay
-
RT-PCR
-
Cell Imaging/Staining
All iGluR Isoforms
MoreAll Endogenous Metabolite Isoforms
More
Biological Activity
|
AMPA Receptor |
DA |
Human Endogenous Metabolite |
Microbial Metabolite |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BHK-21 | EC50 |
1.8 μM
Compound: (S)-Glu
|
Agonist activity at rat NR1/NR2A receptor expressed in BHK21 cells assessed as change in intracellular calcium levels by FLIPR assay
Agonist activity at rat NR1/NR2A receptor expressed in BHK21 cells assessed as change in intracellular calcium levels by FLIPR assay
|
[PMID: 20408529] |
| CHO | EC50 |
1.2 μM
Compound: L-Glutamate
|
Activity at rat mGluR5 by measuring intracellular calcium concentration in CHO cells
Activity at rat mGluR5 by measuring intracellular calcium concentration in CHO cells
|
[PMID: 16213710] |
| CHO | EC50 |
1.2 μM
Compound: L-Glutamate
|
Activity at rat recombinant mGluR5 expressed in CHO cells assessed as intracellular calcium concentration
Activity at rat recombinant mGluR5 expressed in CHO cells assessed as intracellular calcium concentration
|
[PMID: 17350267] |
| CHO | EC50 |
15 μM
Compound: (s)-glu
|
Agonistic activity at mGlu4a receptor expressed in CHO cells
Agonistic activity at mGlu4a receptor expressed in CHO cells
|
[PMID: 8759641] |
| CHO | EC50 |
153 μM
Compound: 157
|
Cytoprotection against glutamate-induced cell death in CHO cells assessed as increase in cell viability by colorimetric assay
Cytoprotection against glutamate-induced cell death in CHO cells assessed as increase in cell viability by colorimetric assay
|
[PMID: 29939744] |
| CHO | EC50 |
16 μM
Compound: 157
|
Agonist activity at mGlu5 receptor (unknown origin) expressed in CHO cells assessed as increase in Gq-mediated PI hydrolysis after 45 mins by yttrium scintillation proximity assay
Agonist activity at mGlu5 receptor (unknown origin) expressed in CHO cells assessed as increase in Gq-mediated PI hydrolysis after 45 mins by yttrium scintillation proximity assay
|
[PMID: 29939744] |
| CHO | EC50 |
19 μM
Compound: (s)-glu
|
Agonistic activity at mGlu1-alpha receptor expressed in CHO cells
Agonistic activity at mGlu1-alpha receptor expressed in CHO cells
|
[PMID: 8759641] |
| CHO | EC50 |
20 μM
Compound: (s)-glu
|
Agonistic activity at mGlu6 receptor expressed in CHO cells
Agonistic activity at mGlu6 receptor expressed in CHO cells
|
[PMID: 8759641] |
| CHO | EC50 |
7.3 μM
Compound: L-Glutamate
|
Activity at rat mGluR1 by measuring intracellular calcium concentration in CHO cells
Activity at rat mGluR1 by measuring intracellular calcium concentration in CHO cells
|
[PMID: 16213710] |
| CHO | EC50 |
7.3 μM
Compound: L-Glutamate
|
Activity at rat recombinant mGluR1 expressed in CHO cells assessed as intracellular calcium concentration
Activity at rat recombinant mGluR1 expressed in CHO cells assessed as intracellular calcium concentration
|
[PMID: 17350267] |
| CHO | EC50 |
7.4 μM
Compound: glutamate
|
Antagonistic activity against stimulation of GTP (gamma) 35 S binding by glutamate in membranes from CHO cells expressing human mGluR2
Antagonistic activity against stimulation of GTP (gamma) 35 S binding by glutamate in membranes from CHO cells expressing human mGluR2
|
[PMID: 11720869] |
| CHO | EC50 |
7.6 μM
Compound: L-Glutamate
|
Activity at rat mGluR6 by measuring cAMP formation in CHO cells
Activity at rat mGluR6 by measuring cAMP formation in CHO cells
|
[PMID: 16213710] |
| CHO | EC50 |
7.6 μM
Compound: L-Glutamate
|
Activity at rat recombinant mGluR6 expressed in CHO cells assessed as cAMP production
Activity at rat recombinant mGluR6 expressed in CHO cells assessed as cAMP production
|
[PMID: 17350267] |
| CHO | EC50 |
8.5 μM
Compound: (s)-glu
|
Agonistic activity at mGlu2 receptor expressed in CHO cells
Agonistic activity at mGlu2 receptor expressed in CHO cells
|
[PMID: 8759641] |
| HEK293 | EC50 |
>100 μM
Compound: Glutamate
|
Agonist activity at rat mGluR7 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
Agonist activity at rat mGluR7 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
|
[PMID: 25958247] |
| HEK293 | EC50 |
0.06 μM
Compound: Glu
|
Agonist activity at rat mGlu3 receptor expressed in HEK293 cells by [35S]GTP-gamma binding assay
Agonist activity at rat mGlu3 receptor expressed in HEK293 cells by [35S]GTP-gamma binding assay
|
[PMID: 26814576] |
| HEK293 | EC50 |
0.06 μM
Compound: Glu
|
Agonist activity at human mGluR3 receptor expressed in HEK cells
Agonist activity at human mGluR3 receptor expressed in HEK cells
|
10.1039/C1MD00186H |
| HEK293 | EC50 |
1.05 μM
Compound: Glutamic acid
|
Effect of compound on Metabotropic glutamate receptor 1 expressed in HEK 293 cells was determined by measuring IP production relative to glutamate
Effect of compound on Metabotropic glutamate receptor 1 expressed in HEK 293 cells was determined by measuring IP production relative to glutamate
|
[PMID: 10673095] |
| HEK293 | EC50 |
1.18 μM
Compound: Glu
|
Agonist activity at human mGlu7 receptor expressed in HEK293 assessed as inhibition of forskolin stimulated cAMP production
Agonist activity at human mGlu7 receptor expressed in HEK293 assessed as inhibition of forskolin stimulated cAMP production
|
[PMID: 26814576] |
| HEK293 | EC50 |
1.6 μM
Compound: Glu
|
Agonist activity at rat mGlu1 receptor expressed in HEK293 cells by intracellular Ca2+ mobilization assay
Agonist activity at rat mGlu1 receptor expressed in HEK293 cells by intracellular Ca2+ mobilization assay
|
[PMID: 26814576] |
| HEK293 | EC50 |
1.6 μM
Compound: Glu
|
Agonist activity at human mGluR1 receptor expressed in HEK cells
Agonist activity at human mGluR1 receptor expressed in HEK cells
|
10.1039/C1MD00186H |
| HEK293 | EC50 |
1.8 μM
Compound: Glu
|
Agonist activity at rat mGlu2 receptor expressed in HEK293 cells by [35S]GTP-gamma binding assay
Agonist activity at rat mGlu2 receptor expressed in HEK293 cells by [35S]GTP-gamma binding assay
|
[PMID: 26814576] |
| HEK293 | EC50 |
1.8 μM
Compound: Glu
|
Agonist activity at human mGluR2 receptor expressed in HEK cells
Agonist activity at human mGluR2 receptor expressed in HEK cells
|
10.1039/C1MD00186H |
| HEK293 | EC50 |
100 μM
Compound: L-Glu
|
Activity at rat cloned iGluR3 expressed in human HEK293 cells by calcium imaging assay
Activity at rat cloned iGluR3 expressed in human HEK293 cells by calcium imaging assay
|
[PMID: 18338843] |
| HEK293 | EC50 |
110 μM
Compound: (S)-Glu
|
Agonist activity at GluR1 E683A/M686V/I687A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
Agonist activity at GluR1 E683A/M686V/I687A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
|
[PMID: 17672447] |
| HEK293 | EC50 |
1180 μM
Compound: Glu
|
Agonist activity at human mGluR7 receptor expressed in HEK cells
Agonist activity at human mGluR7 receptor expressed in HEK cells
|
10.1039/C1MD00186H |
| HEK293 | EC50 |
12.57 μM
Compound: Glutamate
|
Agonist activity at rat mGluR4 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
Agonist activity at rat mGluR4 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
|
[PMID: 25958247] |
| HEK293 | EC50 |
13.08 μM
Compound: Glu
|
Agonist activity at rat mGlu2 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
Agonist activity at rat mGlu2 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
|
[PMID: 26814576] |
| HEK293 | EC50 |
13.65 μM
Compound: Glutamate
|
Agonist activity at rat mGluR5 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
Agonist activity at rat mGluR5 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
|
[PMID: 25958247] |
| HEK293 | EC50 |
13.87 μM
Compound: Glu
|
Agonist activity at rat mGlu1 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
Agonist activity at rat mGlu1 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
|
[PMID: 26814576] |
| HEK293 | EC50 |
130 μM
Compound: L-Glu
|
Activity at rat cloned iGluR5 expressed in human HEK293 cells by calcium imaging assay
Activity at rat cloned iGluR5 expressed in human HEK293 cells by calcium imaging assay
|
[PMID: 18338843] |
| HEK293 | EC50 |
14.01 μM
Compound: Glu
|
Agonist activity at rat mGlu8 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
Agonist activity at rat mGlu8 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
|
[PMID: 26814576] |
| HEK293 | EC50 |
140 μM
Compound: (S)-Glu
|
Agonist activity at GluR1 I687A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
Agonist activity at GluR1 I687A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
|
[PMID: 17672447] |
| HEK293 | EC50 |
140 μM
Compound: (S)-Glu
|
Agonist activity at GluR2Q expressed in HEK293 cells by Fluo-4/Ca2+ assay
Agonist activity at GluR2Q expressed in HEK293 cells by Fluo-4/Ca2+ assay
|
[PMID: 17672447] |
| HEK293 | EC50 |
140 μM
Compound: Glu
|
Agonist activity at rat recombinant GluR5(Q) RNA-edited isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
Agonist activity at rat recombinant GluR5(Q) RNA-edited isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
|
[PMID: 19588945] |
| HEK293 | EC50 |
140 μM
Compound: L-Glu
|
Activity at rat cloned iGluR2 expressed in human HEK293 cells by calcium imaging assay
Activity at rat cloned iGluR2 expressed in human HEK293 cells by calcium imaging assay
|
[PMID: 18338843] |
| HEK293 | EC50 |
16 μM
Compound: 33032
|
Substrate uptake by the Excitatory Amino Acid Transporter 1 (EAAT1, SLC1A3) as assessed by the fluorescent FLIPR membrane potential dye in HEK-293 JumpIN-SLC1A3 cells
Substrate uptake by the Excitatory Amino Acid Transporter 1 (EAAT1, SLC1A3) as assessed by the fluorescent FLIPR membrane potential dye in HEK-293 JumpIN-SLC1A3 cells
|
10.5281/zenodo.6782621 |
| HEK293 | EC50 |
16 μM
Compound: 33032
|
Substrate uptake by the Excitatory Amino Acid Transporter 1 (EAAT1, SLC1A3) as assessed by the fluorescent FLIPR membrane potential dye in HEK-293 JumpIN-SLC1A3 cells (PubChem AID: 1745864)
Substrate uptake by the Excitatory Amino Acid Transporter 1 (EAAT1, SLC1A3) as assessed by the fluorescent FLIPR membrane potential dye in HEK-293 JumpIN-SLC1A3 cells (PubChem AID: 1745864)
|
10.5281/zenodo.6782621 |
| HEK293 | EC50 |
16 μM
Compound: Glutamate
|
Agonist activity in rat at Metabotropic glutamate receptor 2 expressed in HEK293 cells
Agonist activity in rat at Metabotropic glutamate receptor 2 expressed in HEK293 cells
|
[PMID: 11412983] |
| HEK293 | EC50 |
17 μM
Compound: L-Glu
|
Activity at rat cloned iGluR4 expressed in human HEK293 cells by calcium imaging assay
Activity at rat cloned iGluR4 expressed in human HEK293 cells by calcium imaging assay
|
[PMID: 18338843] |
| HEK293 | EC50 |
18.25 μM
Compound: Glutamate
|
Agonist activity at rat mGluR2 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
Agonist activity at rat mGluR2 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
|
[PMID: 25958247] |
| HEK293 | EC50 |
190 μM
Compound: (S)-Glutamate
|
Agonist activity at rat recombinant GluA2 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay
Agonist activity at rat recombinant GluA2 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay
|
[PMID: 20096591] |
| HEK293 | EC50 |
190 μM
Compound: Glu
|
Agonist activity at rat recombinant GluR2(Q) RNA-edited isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
Agonist activity at rat recombinant GluR2(Q) RNA-edited isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
|
[PMID: 19588945] |
| HEK293 | EC50 |
2.88 μM
Compound: 1, Glu
|
Agonist activity at rat mGlu4 receptor expressed in HEK293 cells coexpressing Gq/Gi and EAAC1 assessed as intracellular calcium production measured every 1.5 secs for 60 secs by Fluo-4-AM based fluorometry
Agonist activity at rat mGlu4 receptor expressed in HEK293 cells coexpressing Gq/Gi and EAAC1 assessed as intracellular calcium production measured every 1.5 secs for 60 secs by Fluo-4-AM based fluorometry
|
[PMID: 22750138] |
| HEK293 | EC50 |
20 μM
Compound: (S)-Glutamate
|
Agonist activity at rat recombinant GluA4 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay
Agonist activity at rat recombinant GluA4 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay
|
[PMID: 20096591] |
| HEK293 | EC50 |
20 μM
Compound: Glu
|
Agonist activity at rat recombinant GluR4 flip isomer expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
Agonist activity at rat recombinant GluR4 flip isomer expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
|
[PMID: 19588945] |
| HEK293 | EC50 |
21.47 μM
Compound: Glutamate
|
Agonist activity at rat mGluR8 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
Agonist activity at rat mGluR8 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
|
[PMID: 25958247] |
| HEK293 | EC50 |
22 μM
Compound: 1,Glu
|
Induction of calcium influx in HEK293 cells expressing human GLUK5 by FLIPR assay
Induction of calcium influx in HEK293 cells expressing human GLUK5 by FLIPR assay
|
[PMID: 16610801] |
| HEK293 | EC50 |
23.16 μM
Compound: Glutamate
|
Agonist activity at rat mGluR1 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
Agonist activity at rat mGluR1 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
|
[PMID: 25958247] |
| HEK293 | EC50 |
24 μM
Compound: 1; (S)-Glu
|
Agonist activity at GluA3 receptor (unknown origin) expressed in HEK293 cells assessed induction of S-glutamate-induced calcium flux measured after 90 secs in presence of cyclothiazide by Fluo4-AM dye-based fluorescence assay
Agonist activity at GluA3 receptor (unknown origin) expressed in HEK293 cells assessed induction of S-glutamate-induced calcium flux measured after 90 secs in presence of cyclothiazide by Fluo4-AM dye-based fluorescence assay
|
[PMID: 30943028] |
| HEK293 | EC50 |
25 μM
Compound: Glutamate
|
Compound was tested for agonistic activity at Glutamate receptor 6 using HEK293 cells
Compound was tested for agonistic activity at Glutamate receptor 6 using HEK293 cells
|
[PMID: 10969973] |
| HEK293 | EC50 |
25 μM
Compound: glutamate
|
Effective concentration against human GluR6 expressed in HEK293 cells
Effective concentration against human GluR6 expressed in HEK293 cells
|
[PMID: 10821708] |
| HEK293 | EC50 |
27 μM
Compound: 1,Glu
|
Induction of calcium influx in HEK293 cells expressing human GLUK5/GLUK6 by FLIPR assay
Induction of calcium influx in HEK293 cells expressing human GLUK5/GLUK6 by FLIPR assay
|
[PMID: 16610801] |
| HEK293 | EC50 |
28 μM
Compound: (S)-Glu
|
Agonist activity at GluR4 expressed in HEK293 cells by Fluo-4/Ca2+ assay
Agonist activity at GluR4 expressed in HEK293 cells by Fluo-4/Ca2+ assay
|
[PMID: 17672447] |
| HEK293 | EC50 |
3 μM
Compound: Glutamate
|
Agonist activity in rat at Metabotropic glutamate receptor 1 expressed in HEK293 cells
Agonist activity in rat at Metabotropic glutamate receptor 1 expressed in HEK293 cells
|
[PMID: 11412983] |
| HEK293 | EC50 |
3.2 μM
Compound: Glu
|
Agonist activity at rat mGlu4 receptor expressed in HEK293 cells assessed as inhibition of forskolin stimulated cAMP production
Agonist activity at rat mGlu4 receptor expressed in HEK293 cells assessed as inhibition of forskolin stimulated cAMP production
|
[PMID: 26814576] |
| HEK293 | EC50 |
3.2 μM
Compound: Glu
|
Agonist activity at human mGluR4 receptor expressed in HEK cells
Agonist activity at human mGluR4 receptor expressed in HEK cells
|
10.1039/C1MD00186H |
| HEK293 | EC50 |
33 μM
Compound: 1; (S)-Glu
|
Agonist activity at GluA1 receptor (unknown origin) expressed in HEK293 cells assessed induction of S-glutamate-induced calcium flux measured after 90 secs in presence of cyclothiazide by Fluo4-AM dye-based fluorescence assay
Agonist activity at GluA1 receptor (unknown origin) expressed in HEK293 cells assessed induction of S-glutamate-induced calcium flux measured after 90 secs in presence of cyclothiazide by Fluo4-AM dye-based fluorescence assay
|
[PMID: 30943028] |
| HEK293 | EC50 |
35 μM
Compound: 1,Glu
|
Induction of calcium influx in HEK293 cells expressing human GLUK5/GLUK2 by FLIPR assay
Induction of calcium influx in HEK293 cells expressing human GLUK5/GLUK2 by FLIPR assay
|
[PMID: 16610801] |
| HEK293 | EC50 |
35 μM
Compound: L-Glu
|
Activity at rat cloned iGluR1 expressed in human HEK293 cells by calcium imaging assay
Activity at rat cloned iGluR1 expressed in human HEK293 cells by calcium imaging assay
|
[PMID: 18338843] |
| HEK293 | EC50 |
39 μM
Compound: (S)-Glu
|
Agonist activity at GluR1 E683A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
Agonist activity at GluR1 E683A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
|
[PMID: 17672447] |
| HEK293 | EC50 |
398 μM
Compound: L-glu
|
Inhibition of the Excitatory Amino Acid Transporter 1 (EAAT1, SLC1A3) as assessed by a phenotypic impedance-based assay detecting changes in cell morphology by L-glutamate uptake in HEK-293 JumpIN-SLC1A3 cells
Inhibition of the Excitatory Amino Acid Transporter 1 (EAAT1, SLC1A3) as assessed by a phenotypic impedance-based assay detecting changes in cell morphology by L-glutamate uptake in HEK-293 JumpIN-SLC1A3 cells
|
[PMID: 35677430] |
| HEK293 | EC50 |
398 μM
Compound: L-glu
|
Inhibition of the Excitatory Amino Acid Transporter 1 (EAAT1, SLC1A3) as assessed by a phenotypic impedance-based assay detecting changes in cell morphology by L-glutamate uptake in HEK-293 JumpIN-SLC1A3 cells (PubChem AID: 1745862)
Inhibition of the Excitatory Amino Acid Transporter 1 (EAAT1, SLC1A3) as assessed by a phenotypic impedance-based assay detecting changes in cell morphology by L-glutamate uptake in HEK-293 JumpIN-SLC1A3 cells (PubChem AID: 1745862)
|
[PMID: 35677430] |
| HEK293 | EC50 |
4.7 μM
Compound: Glu
|
Agonist activity at rat mGlu5 receptor expressed in HEK293 cells by intracellular Ca2+ mobilization assay
Agonist activity at rat mGlu5 receptor expressed in HEK293 cells by intracellular Ca2+ mobilization assay
|
[PMID: 26814576] |
| HEK293 | EC50 |
4.7 μM
Compound: Glu
|
Agonist activity at human mGluR5 receptor expressed in HEK cells
Agonist activity at human mGluR5 receptor expressed in HEK cells
|
10.1039/C1MD00186H |
| HEK293 | EC50 |
4.8 μM
Compound: 1; (S)-Glu
|
Agonist activity at GluA4 receptor (unknown origin) expressed in HEK293 cells assessed induction of S-glutamate-induced calcium flux measured after 90 secs in presence of cyclothiazide by Fluo4-AM dye-based fluorescence assay
Agonist activity at GluA4 receptor (unknown origin) expressed in HEK293 cells assessed induction of S-glutamate-induced calcium flux measured after 90 secs in presence of cyclothiazide by Fluo4-AM dye-based fluorescence assay
|
[PMID: 30943028] |
| HEK293 | EC50 |
51 μM
Compound: (S)-Glutamate
|
Agonist activity at rat recombinant GluA1 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay
Agonist activity at rat recombinant GluA1 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay
|
[PMID: 20096591] |
| HEK293 | EC50 |
51 μM
Compound: Glu
|
Agonist activity at rat recombinant GluR1 flip isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
Agonist activity at rat recombinant GluR1 flip isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
|
[PMID: 19588945] |
| HEK293 | EC50 |
52 μM
Compound: (S)-Glutamate
|
Agonist activity at rat recombinant GluA3 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay
Agonist activity at rat recombinant GluA3 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay
|
[PMID: 20096591] |
| HEK293 | EC50 |
52 μM
Compound: Glu
|
Agonist activity at rat recombinant GluR3 flip isomer expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
Agonist activity at rat recombinant GluR3 flip isomer expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
|
[PMID: 19588945] |
| HEK293 | EC50 |
57 μM
Compound: 1; (S)-Glu
|
Agonist activity at GluA2(Q) receptor (unknown origin) expressed in HEK293 cells assessed induction of S-glutamate-induced calcium flux measured after 90 secs in presence of cyclothiazide by Fluo4-AM dye-based fluorescence assay
Agonist activity at GluA2(Q) receptor (unknown origin) expressed in HEK293 cells assessed induction of S-glutamate-induced calcium flux measured after 90 secs in presence of cyclothiazide by Fluo4-AM dye-based fluorescence assay
|
[PMID: 30943028] |
| HEK293 | EC50 |
60 μM
Compound: (S)-Glu
|
Agonist activity at GluR1 D399S/M686V/I687A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
Agonist activity at GluR1 D399S/M686V/I687A mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
|
[PMID: 17672447] |
| HEK293 | EC50 |
63 μM
Compound: (S)-Glu
|
Agonist activity at GluR1 M686V mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
Agonist activity at GluR1 M686V mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
|
[PMID: 17672447] |
| HEK293 | EC50 |
65.09 μM
Compound: Glu
|
Agonist activity at rat mGlu6 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
Agonist activity at rat mGlu6 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
|
[PMID: 26814576] |
| HEK293 | EC50 |
66 μM
Compound: L-Glu
|
Activity at rat cloned iGluR6 expressed in human HEK293 cells by calcium imaging assay
Activity at rat cloned iGluR6 expressed in human HEK293 cells by calcium imaging assay
|
[PMID: 18338843] |
| HEK293 | EC50 |
67 μM
Compound: (S)-Glu
|
Agonist activity at GluR3 expressed in HEK293 cells by Fluo-4/Ca2+ assay
Agonist activity at GluR3 expressed in HEK293 cells by Fluo-4/Ca2+ assay
|
[PMID: 17672447] |
| HEK293 | EC50 |
69 μM
Compound: (S)-Glu
|
Agonist activity at GluR1 D399S mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
Agonist activity at GluR1 D399S mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
|
[PMID: 17672447] |
| HEK293 | EC50 |
71 μM
Compound: (S)-Glu
|
Agonist activity at GluR1 expressed in HEK293 cells by Fluo-4/Ca2+ assay
Agonist activity at GluR1 expressed in HEK293 cells by Fluo-4/Ca2+ assay
|
[PMID: 17672447] |
| HEK293 | EC50 |
73 μM
Compound: Glu
|
Agonist activity at rat recombinant GluR6(Q) RNA-edited isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
Agonist activity at rat recombinant GluR6(Q) RNA-edited isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay
|
[PMID: 19588945] |
| HEK293 | EC50 |
75 μM
Compound: Glutamate
|
Compound was tested for agonistic activity at Glutamate receptor 5 using HEK293 cells
Compound was tested for agonistic activity at Glutamate receptor 5 using HEK293 cells
|
[PMID: 10969973] |
| HEK293 | EC50 |
75 μM
Compound: glutamate
|
Effective concentration against GluR5 expressed in HEK293 cells
Effective concentration against GluR5 expressed in HEK293 cells
|
[PMID: 10821708] |
| HEK293 | EC50 |
76 μM
Compound: (S)-Glu
|
Agonist activity at GluR1 M686V/I687 mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
Agonist activity at GluR1 M686V/I687 mutant expressed in HEK293 cells by Fluo-4/Ca2+ assay
|
[PMID: 17672447] |
| HEK293 | EC50 |
8 μM
Compound: Glutamate
|
Agonist activity in rat at Metabotropic glutamate receptor 8 expressed in HEK293 cells
Agonist activity in rat at Metabotropic glutamate receptor 8 expressed in HEK293 cells
|
[PMID: 11412983] |
| HEK293 | EC50 |
8.99 μM
Compound: Glu
|
Agonist activity at rat mGlu5 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
Agonist activity at rat mGlu5 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
|
[PMID: 26814576] |
| HEK293 | EC50 |
82.21 μM
Compound: Glutamate
|
Agonist activity at rat mGluR6 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
Agonist activity at rat mGluR6 expressed in HEK293 cells assessed as induction of inositol phosphate production by HTRF assay
|
[PMID: 25958247] |
| HEK293 | EC50 |
9.49 μM
Compound: Glu
|
Agonist activity at rat mGlu4 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
Agonist activity at rat mGlu4 receptor expressed in HEK293 cells assessed as IP1 accumulation by IP-One functional assay
|
[PMID: 26814576] |
| Neuron | EC50 |
35.2 μM
Compound: glutamate
|
Effective concentration against Dorsal root ganglia (DRG) neurones
Effective concentration against Dorsal root ganglia (DRG) neurones
|
[PMID: 10821708] |
| Oocyte | EC50 |
0.45 μM
Compound: 1, Glu
|
Activity at rat NR1/NR2D receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology
Activity at rat NR1/NR2D receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology
|
[PMID: 18578474] |
| Oocyte | EC50 |
1 μM
Compound: 1, Glu
|
Activity at rat recombinant NR1/NR2C receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology
Activity at rat recombinant NR1/NR2C receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology
|
[PMID: 18578474] |
| Oocyte | EC50 |
1.3 μM
Compound: (S)-Glutamate
|
Agonist activity at rat recombinant GluA3 receptor flop isoform expressed in Xenopus oocytes
Agonist activity at rat recombinant GluA3 receptor flop isoform expressed in Xenopus oocytes
|
[PMID: 20096591] |
| Oocyte | EC50 |
1.8 μM
Compound: 1, Glu
|
Activity at rat recombinant NR1/NR2B receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology
Activity at rat recombinant NR1/NR2B receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology
|
[PMID: 18578474] |
| Oocyte | EC50 |
108 μM
Compound: (S)-Glu
|
Agonist activity at rat GluK2 mutant expressed in Xenopus oocytes by two-electrode voltage-clamp electrophysiology
Agonist activity at rat GluK2 mutant expressed in Xenopus oocytes by two-electrode voltage-clamp electrophysiology
|
[PMID: 21619066] |
| Oocyte | EC50 |
11 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA2A3 receptor flop isoform expressed in Xenopus oocytes
Agonist activity at recombinant GluA2A3 receptor flop isoform expressed in Xenopus oocytes
|
[PMID: 20096591] |
| Oocyte | EC50 |
14 μM
Compound: (S)-Glu
|
Activity at recombinant iGluR2 receptor expressed in Xenopus laevis oocytes using holding potential of -15 to -20 mV by TEVC electrophysiology
Activity at recombinant iGluR2 receptor expressed in Xenopus laevis oocytes using holding potential of -15 to -20 mV by TEVC electrophysiology
|
[PMID: 20408529] |
| Oocyte | EC50 |
18 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA1A2 receptor flop isoform expressed in Xenopus oocytes
Agonist activity at recombinant GluA1A2 receptor flop isoform expressed in Xenopus oocytes
|
[PMID: 20096591] |
| Oocyte | EC50 |
2.19 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA2 receptor flop isoform expressed in Xenopus oocytes co-expressing gamma2-TARP
Agonist activity at recombinant GluA2 receptor flop isoform expressed in Xenopus oocytes co-expressing gamma2-TARP
|
[PMID: 20096591] |
| Oocyte | EC50 |
2.26 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA1 receptor flip isoform expressed in Xenopus oocytes co-expressing gamma2-TARP
Agonist activity at recombinant GluA1 receptor flip isoform expressed in Xenopus oocytes co-expressing gamma2-TARP
|
[PMID: 20096591] |
| Oocyte | EC50 |
2.75 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA4 receptor flop isoform expressed in Xenopus oocytes co-expressing gamma2-TARP
Agonist activity at recombinant GluA4 receptor flop isoform expressed in Xenopus oocytes co-expressing gamma2-TARP
|
[PMID: 20096591] |
| Oocyte | EC50 |
2.9 μM
Compound: 1, Glu
|
Activity at rat recombinant NR1/NR2A receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology
Activity at rat recombinant NR1/NR2A receptor expressed in Xenopus oocytes assessed as effect on glutamate-induced current by two voltage clamp electrophysiology
|
[PMID: 18578474] |
| Oocyte | EC50 |
22 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA1 receptor flop isoform expressed in Xenopus oocytes
Agonist activity at recombinant GluA1 receptor flop isoform expressed in Xenopus oocytes
|
[PMID: 20096591] |
| Oocyte | EC50 |
3.5 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA2A4 receptor flop isoform expressed in Xenopus oocytes
Agonist activity at recombinant GluA2A4 receptor flop isoform expressed in Xenopus oocytes
|
[PMID: 20096591] |
| Oocyte | EC50 |
3.66 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA3 receptor flop isoform expressed in Xenopus oocytes co-expressing gamma2-TARP
Agonist activity at recombinant GluA3 receptor flop isoform expressed in Xenopus oocytes co-expressing gamma2-TARP
|
[PMID: 20096591] |
| Oocyte | EC50 |
32.3 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA2A4 receptor flip isoform expressed in Xenopus oocytes
Agonist activity at recombinant GluA2A4 receptor flip isoform expressed in Xenopus oocytes
|
[PMID: 20096591] |
| Oocyte | EC50 |
35 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA3 receptor flop isoform expressed in Xenopus oocytes
Agonist activity at recombinant GluA3 receptor flop isoform expressed in Xenopus oocytes
|
[PMID: 20096591] |
| Oocyte | EC50 |
6.16 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA1A2 receptor flip isoform expressed in Xenopus oocytes
Agonist activity at recombinant GluA1A2 receptor flip isoform expressed in Xenopus oocytes
|
[PMID: 20096591] |
| Oocyte | EC50 |
6.2 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA2 receptor flop isoform expressed in Xenopus oocytes
Agonist activity at recombinant GluA2 receptor flop isoform expressed in Xenopus oocytes
|
[PMID: 20096591] |
| Oocyte | EC50 |
6.4 μM
Compound: (S)-Glutamate
|
Agonist activity at rat recombinant GluA1 receptor flop isoform expressed in Xenopus oocytes
Agonist activity at rat recombinant GluA1 receptor flop isoform expressed in Xenopus oocytes
|
[PMID: 20096591] |
| Oocyte | EC50 |
8.1 μM
Compound: (S)-Glutamate
|
Agonist activity at recombinant GluA4 receptor flop isoform expressed in Xenopus oocytes
Agonist activity at recombinant GluA4 receptor flop isoform expressed in Xenopus oocytes
|
[PMID: 20096591] |
| Oocyte | EC50 |
83.5 μM
Compound: (S)-Glu
|
Agonist activity at Non-desensitized homomeric rat GluK1(Q)1b mutant expressed in Xenopus oocytes by two-electrode voltage-clamp electrophysiology
Agonist activity at Non-desensitized homomeric rat GluK1(Q)1b mutant expressed in Xenopus oocytes by two-electrode voltage-clamp electrophysiology
|
[PMID: 21619066] |
| Oocyte | EC50 |
9030 μM
Compound: (S)-Glu
|
Agonist activity at non-desensitized homomeric rat GluK3 mutant expressed in Xenopus oocytes by two-electrode voltage-clamp electrophysiology
Agonist activity at non-desensitized homomeric rat GluK3 mutant expressed in Xenopus oocytes by two-electrode voltage-clamp electrophysiology
|
[PMID: 21619066] |
L-Glutamic acid (120, 500, 750, 1000 mg/dL) can reduce the harmful effect of lithium on the embryonic development of Xenopus Xenopus[3].
L-Glutamic acid (2, 5, 10, 20 mM, 24-48 h) can induce neuroexcitotoxicity in neuroblastoma[4].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SH-SY5Y, IMR-32, SK-N-BE(2)
-
Concentration:2, 5, 10, 20 mM
-
Incubation Time:24 and 48 h
-
Result:Reduced cell viability in a dose-dependent manner.
L-Glutamic acid (750 mg/kg, intraperitoneal injection) can reduce and inhibit oxidative stress induced by chlorpyrifos (CPF) in rats[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Crv4 mice model[1]
-
Dosage:3 g/kg
-
Administration:s.c., single dose
-
Result:Reduced the number of Brn-3a+ RGCs by >70%. In the absence of mGlu1 receptor, MSG-induced retinal damage is diminished.
-
Animal Model:CPF-induced rat model[5]
-
Dosage:750 mg/kg
-
Administration:i.p.
-
Result:Reduced CPF-induced oxidative stress by increasing the level of GSH and activity of GSH-related enzymes.
Chemical Information
-
CAS No. 56-86-0
-
Appearance Solid
-
Molecular Weight 147.13
-
Formula C5H9NO4
-
Color White to off-white
-
SMILES
OC(CC[C@H](N)C(O)=O)=O
-
Structure Classification
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Store at room temperature 3 years
In solvent -80°C 2 years -20°C 1 year
Publications (15)
-
Journal Impact Factor
-
Most Recent
-
Nature
2025 Jul;643(8070):192-200. PMID: 39695227 -
Adv Sci (Weinh)
Assessing the Nature of Human Brain-Derived Extracellular Vesicles on Synaptic Activity Via the Development of an Air-liquid Microfluidic Platform. [Abstract]2025 Oct 5:e11194. PMID: 41047484
L-Glutamic acid purchased from MedChemExpress. Usage Cited in: Adv Sci (Weinh). 2025 Oct 5:e11194. [Abstract]
L-Glutamic acid (100 µM; 10 min) for activation of spike count. Spontaneous LFP activity is recorded from OPAB that has been pre-treated with Bicuculline and stimulated with L-Glutamic acid. The LFP signal from the activated OPAB is measured (pre), and then the electrical signal is inhibited for 10 min using a cocktail of TTX, CNQX, and AP5 and LFP was recorded again (post).
-
Adv Sci (Weinh)
Addressing Clinical Limitations of Glutaminase Inhibitors: Novel Strategies for Osimertinib-Resistant Lung Cancer by Exploiting Glutamine Metabolic Dependency. [Abstract]2024 Dec 16:e2411479. PMID: 39680480 -
Redox Biol
Enteric coronavirus PDCoV evokes a non-Warburg effect by hijacking pyruvic acid as a metabolic hub. [Abstract]2024 May:71:103112. PMID: 38461791 -
J Transl Med
HuR promotes castration-resistant prostate cancer progression by altering ERK5 activation via posttranscriptional regulation of BCAT1. [Abstract]2024 Feb 18;22(1):178. PMID: 38369471
L-Glutamic acid purchased from MedChemExpress. Usage Cited in: J Transl Med. 2024 Feb 18;22(1):178. [Abstract]
PC3 and DU145 cells were treated with 10 μM glutamate for 24 h, after which the protein expression levels were analysed by western blotting. The expression intensity was normalized to that of β-tubulin (right panel).
-
Cancer Immunol Immunother
2025 Jun 7;74(8):240. PMID: 40481876
L-Glutamic acid purchased from MedChemExpress. Usage Cited in: Cancer Immunol Immunother. 2025 Jun 7;74(8):240. [Abstract]
Flow cytometry representative image showing the effect of exogenous glutamate (1 mM) on mouse primary T cells.
-
Int Immunopharmacol
CGRP alleviates epilepsy via JAK1-STAT1-P2RX7 signaling: a novel neuroprotective axis targeting neuronal damage. [Abstract]2025 Dec 21:170:116080. PMID: 41429063 -
Neuropharmacology
Neurotransmitter imbalance and amygdala synaptic plasticity in lumbar disc herniation-induced chronic pain and related emotional Disturbances:A multi-omics analysis. [Abstract]2025 Jun 15:271:110405. PMID: 40057176 -
J Inflamm Res
Lactate Ameliorates Kainic Acid-Induced Neuroinflammation and Cognitive Impairment via the Chemokine Signaling Pathway in Mice. [Abstract]2025 Jan 27:18:1235-1254. PMID: 39897526
L-Glutamic acid purchased from MedChemExpress. Usage Cited in: J Inflamm Res. 2025 Jan 27:18:1235-1254. [Abstract]
Viability of HT22 cells treated with Glutamate at different concentrations (0, 5, 10, 15, 20 and 25 mM) for 24 h (n=5 at each concentration).
L-Glutamic acid purchased from MedChemExpress. Usage Cited in: J Inflamm Res. 2025 Jan 27:18:1235-1254. [Abstract]
The relative mRNA expression levels of c-fos in the control, glu (20 mM, 24 h) and lactate groups (n=6 in each group).
L-Glutamic acid purchased from MedChemExpress. Usage Cited in: J Inflamm Res. 2025 Jan 27:18:1235-1254. [Abstract]
Fluorescence images of TUNEL staining of HT22 cells in the control, glu (20 mM, 24 h) and lactate groups.
L-Glutamic acid purchased from MedChemExpress. Usage Cited in: J Inflamm Res. 2025 Jan 27:18:1235-1254. [Abstract]
Images of VGLUT1 fluorescence staining in HT22 cells from the control, glu (20 mM, 24 h) and lactate groups.
-
Neurochem Int
Glutamate-aspartate transporter dysfunction enhances aminoglycoside-induced cochlear hair cell death via NMDA receptor activation. [Abstract]2023 Oct:169:105587. PMID: 37495172 -
Fitoterapia
The stem-derived bioactive fraction of Syringa oblata Lindl. Ameliorates insomnia via cAMP signaling-mediated regulation of neurotransmission, oxidative stress, and inflammation: A multi-omics study. [Abstract]2026 Apr:190:107182. PMID: 41861857 -
Amino Acids
Identification of amino acids metabolomic profiling in human plasma distinguishes lupus nephritis from systemic lupus erythematosus. [Abstract]2024 Sep 18;56(1):56. PMID: 39292313 -
-
-
Solvent & Solubility
H2O : 6.25 mg/mL (42.48 mM; Need ultrasonic)
DMSO : < 1 mg/mL (insoluble or slightly soluble)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
For the following dissolution methods, please prepare the working solution directly:
It is recommended to prepare fresh solutions and use them promptly within a short period of time.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: PBS
Solubility: 9.09 mg/mL (61.78 mM); Clear solution; Need ultrasonic and warming and heat to 60°C
Purity & Documentation
-
Data Sheet (280 KB)
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Handling Instructions (2659 KB)
References
[1]. Liberatore F, et al. Permissive role for mGlu1 metabotropic glutamate receptors in excitotoxic retinal degeneration. Neuroscience. 2017 Nov 5;363:142-149. [Content Brief]
[2]. Giorguieff MF, et al. Presynaptic effect of L-glutamic acid on the release of dopamine in rat striatal slices. Neurosci Lett. 1977 Oct;6(1):73-7. [Content Brief]
[3]. Boga Pekmezekmek A, et al. L-Glutamic acid monosodium salt reduces the harmful effect of lithium on the development of Xenopus laevis embryos. Environ Sci Pollut Res Int. 2020 Nov;27(33):42124-42132. [Content Brief]
[4]. Croce N, et al. Hydrochloric acid alters the effect of L-glutamic acid on cell viability in human neuroblastoma cell cultures. J Neurosci Methods. 2013 Jul 15;217(1-2):26-30. [Content Brief]
[5]. Salyha N, et al. Protective role of l-glutamic acid and l-cysteine in mitigation the chlorpyrifos-induced oxidative stress in rats. Environ Toxicol Pharmacol. 2018 Dec;64:155-163. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| H2O | 1 mM | 6.7967 mL | 33.9836 mL | 67.9671 mL | 169.9178 mL |
| 5 mM | 1.3593 mL | 6.7967 mL | 13.5934 mL | 33.9836 mL | |
| 10 mM | 0.6797 mL | 3.3984 mL | 6.7967 mL | 16.9918 mL | |
| 15 mM | 0.4531 mL | 2.2656 mL | 4.5311 mL | 11.3279 mL | |
| 20 mM | 0.3398 mL | 1.6992 mL | 3.3984 mL | 8.4959 mL | |
| 25 mM | 0.2719 mL | 1.3593 mL | 2.7187 mL | 6.7967 mL | |
| 30 mM | 0.2266 mL | 1.1328 mL | 2.2656 mL | 5.6639 mL | |
| 40 mM | 0.1699 mL | 0.8496 mL | 1.6992 mL | 4.2479 mL |
* Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.